businesspress24.com - Massachusetts Ketamine IV Therapy For Chronic Pain and Depression Relief
 

Massachusetts Ketamine IV Therapy For Chronic Pain and Depression Relief

ID: 688716

Thrive IV (508 848-8089) in Dartmouth Massachusetts has announced a physician-approved ketamine IV therapy to relieve symptoms associated with chronic pain and depression conditions.

(firmenpresse) - With this announcement, Thrive IV offers patients who suffer from these conditions, as well as fibromyalgia, chronic migraine headaches, phantom limb pain, or pain related to trauma, stroke, spinal injuries, MS, Lyme and depression an effective alternative to pain and SSRI medications.
Interested parties can learn more at https://www.thriveiv.net/
With up to 40% of American adults suffering from chronic pain-related symptoms, the clinic s ketamine IV therapy is intended to provide long-term relief for those patients who have not responded well to traditional treatments.
Ketamine is an anaesthetic shown in recent studies to be beneficial in diminishing chronic pain due to conditions like neuralgia, neuropathic pain from peripheral nerve damage, complex regional pain syndrome, cancer-related neuropathic pain, post-operative pain, and more. It has clearly been shown to elevate mood and rewire the brain to stop depression.
Ketamine is able to block the N-methyl-D-aspartate receptor (NMDAR) which plays an important role in the development and chronic pain and the persistent depressive and sad, hopeless thoughts. This substance interacts with patients neural pathways to help undo signals that elicit a pain response as well as reverse and regrow the nerve connections that will elevate mood and stop depression. Ketamine has also been proven highly effective in alleviating depression, which is a condition that many chronic pain patients develop.
At Thrive IV, patients with chronic nerve pain conditions often receive a Two to 4-hour ketamine IV infusion to begin their treatment. During the therapy sessions, patients vital signs will be monitored carefully by Thrive IV staff, who also adjust the IV treatment based on a patient s response.
Mood infusions for depression, PTSD and anxiety are usually 6 treatments each approximately 40minutes to an hour administered over the course of 2-4 weeks.
Thrive IV said it strives to issue the least amount of ketamine sessions necessary to alleviate a patient s pain and or overwhelming depressive thoughts and feelings. On average, patients receive a series of six infusions over a 2-4 week period. Pain infusions may be only needed as a single infusion or depending on the specific time of pain, it may be necessary to have several infusions over weeks.




Located in Dartmouth, Massachusetts, Thrive IV was founded by Dr. Michael Pellegrino who has been serving communities in the southeastern Massachusetts region since 1996. Dr. Pellegrino has clinical experience not only in Ketamine therapy but also in osteopathy, acupuncture, and is certified in emergency medicine.
Thrive IV also offers vitamin infusion therapies for ketamine patients and for a wide range of goals, including stronger immunity, exercise support, better hydration, and nutrition supplementation as well as to help increase the success of the ketamine therapy infusions.
"We specialize in adding Ketamine infusions to help increase your feeling of well-being and reduce the terrible pain, depression, or anxiety you ve been experiencing," a spokesperson from the clinic said.
Interested parties can learn more and schedule a consultation with Thrive IV by visiting https://www.thriveiv.net/


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:

Thrive IV



Leseranfragen:

hrive IV
http://www.ThriveIV.net
ThriveIVKetamine(at)gmail.com
+1-508-848-8089
49 State Rd Nauset Building #102
Dartmouth



drucken  als PDF  an Freund senden  
Bereitgestellt von Benutzer: others
Datum: 04.08.2023 - 13:50 Uhr
Sprache: Deutsch
News-ID 688716
Anzahl Zeichen: 0

contact information:
Contact person: Dr. Michael Pellegrino
Town:

Dartmouth


Phone: +1-508-848-8089

Kategorie:


Typ of Press Release: Unternehmensinformation
type of sending: Veröffentlichung
Date of sending: 04/08/2023

Diese Pressemitteilung wurde bisher 95 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Massachusetts Ketamine IV Therapy For Chronic Pain and Depression Relief"
steht unter der journalistisch-redaktionellen Verantwortung von

Thrive IV (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Thrive IV



 

Who is online

All members: 10 563
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 74


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.